AU5255793A - Process for preparing recombinant and synthetic peptides, and their use - Google Patents
Process for preparing recombinant and synthetic peptides, and their useInfo
- Publication number
- AU5255793A AU5255793A AU52557/93A AU5255793A AU5255793A AU 5255793 A AU5255793 A AU 5255793A AU 52557/93 A AU52557/93 A AU 52557/93A AU 5255793 A AU5255793 A AU 5255793A AU 5255793 A AU5255793 A AU 5255793A
- Authority
- AU
- Australia
- Prior art keywords
- synthetic peptides
- peptides
- preparing recombinant
- microorganisms
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 244000005700 microbiome Species 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/089—Cytomegalovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
- C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Abstract
The invention relates to a process for the production of peptides which bind to a predetermined specific binding partner, which includes the setting up of a nucleotide bank, the transformation of microorganisms, the cultivation of the transformed microorganisms and the selection of the microorganisms which express the peptides which are sought, and to the use of such peptides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4243770A DE4243770A1 (en) | 1992-12-23 | 1992-12-23 | Process for the production of recombinant and synthetic peptides and their use |
DE4243770 | 1992-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU5255793A true AU5255793A (en) | 1994-07-07 |
AU669947B2 AU669947B2 (en) | 1996-06-27 |
Family
ID=6476332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52557/93A Ceased AU669947B2 (en) | 1992-12-23 | 1993-12-21 | Process for preparing recombinant and synthetic peptides, and their use |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0603672B1 (en) |
JP (1) | JP3386210B2 (en) |
AT (1) | ATE190653T1 (en) |
AU (1) | AU669947B2 (en) |
CA (1) | CA2112193A1 (en) |
DE (2) | DE4243770A1 (en) |
ES (1) | ES2144438T3 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932425A (en) * | 1997-02-18 | 1999-08-03 | Signal Pharmaceuticals, Inc. | Compositions and methods for modulating cellular NF-κB activation |
US7553636B2 (en) * | 2001-08-10 | 2009-06-30 | Bioleaders Corporation | Surface expression vectors having pgsBCA the gene coding poly-gamma-glutamate synthetase, and a method for expression of target protein at the surface of microorganism using the vector |
JP4351430B2 (en) | 2002-10-04 | 2009-10-28 | 財団法人癌研究会 | Peptide having binding ability to nanographite structure |
KR20200000972A (en) | 2018-06-26 | 2020-01-06 | 주식회사 바이오리더스 | SURFACE EXPRESSION VECTORS INCLUDING pgsA, GENE ENCODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND METHOD OF USING VECTORS TO EXPRESS TARGET PROTEIN ON SURFACE OF MICROORGANISM |
EP3865578A4 (en) | 2018-10-10 | 2022-08-24 | Bioleaders Corporation | Surface expression vector for constitutive high-expression using promoter of galactose mutarotase gene derived from lactobacillus casei, and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5427908A (en) * | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
US5650489A (en) * | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
-
1992
- 1992-12-23 DE DE4243770A patent/DE4243770A1/en not_active Withdrawn
-
1993
- 1993-12-10 AT AT93119921T patent/ATE190653T1/en not_active IP Right Cessation
- 1993-12-10 DE DE59309978T patent/DE59309978D1/en not_active Expired - Fee Related
- 1993-12-10 ES ES93119921T patent/ES2144438T3/en not_active Expired - Lifetime
- 1993-12-10 EP EP93119921A patent/EP0603672B1/en not_active Expired - Lifetime
- 1993-12-21 AU AU52557/93A patent/AU669947B2/en not_active Ceased
- 1993-12-22 CA CA002112193A patent/CA2112193A1/en not_active Abandoned
- 1993-12-24 JP JP34809493A patent/JP3386210B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2112193A1 (en) | 1994-06-24 |
EP0603672B1 (en) | 2000-03-15 |
EP0603672A3 (en) | 1995-03-15 |
AU669947B2 (en) | 1996-06-27 |
DE59309978D1 (en) | 2000-04-20 |
JPH07303493A (en) | 1995-11-21 |
ES2144438T3 (en) | 2000-06-16 |
EP0603672A2 (en) | 1994-06-29 |
JP3386210B2 (en) | 2003-03-17 |
ATE190653T1 (en) | 2000-04-15 |
DE4243770A1 (en) | 1994-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU630950B2 (en) | Fibronectin binding protein as well as its preparation | |
AU4453689A (en) | Binding protein for insulin-like growth factors | |
PL313256A1 (en) | Protocadherine proteins and their applications | |
EP0200909A3 (en) | Preparation of protein g and/or fragments thereof | |
FI101542B1 (en) | Chemical synthesis process for preparing a fibronectin binding protein or polypeptide | |
CA2117581A1 (en) | Protocadherin, their antibodies and uses | |
AU669947B2 (en) | Process for preparing recombinant and synthetic peptides, and their use | |
IE801912L (en) | Gaming machine | |
CA2088068A1 (en) | Protein structure of the plant toxin gelonin | |
AU5045493A (en) | Process for preparing conjugates consisting of a specific binding partner and a carbohydrate-containing protein | |
ATE170537T1 (en) | REACTIVE, WATER EMULSIFIABLE BINDERS AND THEIR USE FOR PRODUCING PAINTS | |
EP0828004A3 (en) | Protein disulfide isomerase gene derived from strain of methylotrophic yeast | |
EP1308514A3 (en) | ICAM-4 Materials and Methods | |
DE58906674D1 (en) | Process for the selection of productive, amino acid-excreting strains of microorganisms. | |
EP0771876A4 (en) | PROCESS FOR PRODUCING cis-3-HYDROXY-L-PROLINE | |
MX9703431A (en) | Dna sequence and its use. | |
AU2076001A (en) | Modified full length promoters | |
GB9226928D0 (en) | Novel immunoglobulin binding proteins,process for their production & recombinant dna molecules coding therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |